Stock of the Week <style type="text/css">.ReadMsgBody { width: 100%; background-color: #E6F0FA; } .ExternalClass { width: 100%; background-color: #E6F0FA; } .ExternalClass, .ExternalClass p, .ExternalClass span, .ExternalClass font, .ExternalClass td, .ExternalClass div { line-height: 100%; } body { margin: 0; padding: 0; -webkit-text-size-adjust: none; -ms-text-size-adjust: none; } div, p, a, li, td { -webkit-text-size-adjust: none; -ms-text-size-adjust: none; } table td { -webkit-text-size-adjust: none; border-spacing: 0; border-collapse: collapse; border:0 none; mso-table-lspace: 0pt; mso-table-rspace: 0pt; } a[href^="https"] { text-decoration: none; } /* Constrain email width for small screens */ @media screen and (max-width: 650px) { table[class="container"] { width: 96%!important; -moz-box-sizing:border-box; -webkit-box-sizing:border-box; box-sizing:border-box; margin:0 auto; } } /* Styles for forcing columns to rows */ @media only screen and (max-width : 650px) { /* force container columns to (horizontal) blocks */ td[class="force-col"] { display: block; text-align: left; width: auto!important; } img[class="fullwidth-img"] { width: 100%!important; } /* Make telephone numbers pretty */ a[href~="tel"] { color:#d35400!important; } /* OFFERS TABLE LAYOUT */ td[class="offers-table-header-force-col"] { border-bottom:none!important; display: block; text-align: left; width: auto!important; } td[class="offers-table-force-col"] { display: block; text-align: left; width: auto!important; padding:0 10px 10px!important; } /* TEXT WITH IMAGE LAYOUT */ td[class="textimg-img-col"] { border-bottom:none!important; display: block; text-align: left; width: auto!important; padding:10px 10px 0!important } td[class="textimg-text"] { border-bottom:none!important; display: block; text-align: left; width: auto!important; } /* 3 COL LAYOUTS */ table[class="col-3"] { border-bottom:1px solid #535353; margin-bottom:12px; } table[id="last-col-3"] { border-bottom:none; margin-bottom:0; } img[class="col-3-img"] { float: right; margin-left: 6px; max-width: 130px; } }</style>

Stock of the Week Logo
One Big Pick. Once a Week.


PNGAF IS A "GROUND FLOOR" FDA DECISION PLAY WITH IMMENSE UPSIDE POTENTIAL & COULD GO VIRAL!



logo
PRECISION PEPTIDE COMPANY INC

US OTC SYMBOL: PNGAF

Canada: PNGA
Last Price: .33  |    Website   |    SEC Filings   |    Latest News

Disseminated on behalf of Precision Peptide Company Inc.


Let's talk about what's quietly becoming one of the most explosive trends in the global health and wellness market: Peptides.

The word alone used to conjure images of elite athletes jabbing needles in locker rooms. But that's changing FAST . The global peptide therapeutics market was valued at $140.86 BILLION in 2025 and is projected to climb to $260+ BILLION by 2030.

Tonight we present a unique GROUND FLOOR SITUATION for a duel-listed (US OTCQB & Canada CSE) stock that has a proprietary tech that aims to solve the biggest single barrier to mass adoption of Peptides use. 

We are talking about a 33 CENTS stock that isn't only aiming to GROW the market, but literally UNLOCK it to the masses. This Hidden Gem could soon catch fire as Wall Street becomes aware of its immense long-term potential...

WE ARE ISSUING AN IMMEDIATE ALERT ON PNGAF FOR TOMORROW!

Precision Peptide Company Inc (OTCQB: PNGAF) (formerly Pangea Natural Food Inc) is a publicly traded wellness company building a next-generation platform for high-quality peptide formulations and delivery systems. Based in Vancouver, BC, the company combines scientific formulation with innovative delivery technologies — creating products at the intersection of biotechnology and scalable consumer wellness.

Founded in Vancouver, British Columbia, PNGAF emerged from a vision to revolutionize the health and wellness industry with a simple yet powerful idea: create premium wellness products that honour traditional wisdom while embracing modern innovation.

Through its subsidiary Amino Innovations, PNGAF is also aiming to take advantage of the PEPTIDE REVOLUTION!

Peptides are not cheap by any measure. And most likely, your favorite celebrities who seem to never age are using them!

The trend continues to grow as the global peptide therapeutics market was estimated at USD $117 BILLION in 2024 and projected to reach $260 BILLION by 2030!!!

SO WHAT ARE PEPTIDES?

peptides

Peptides are short chains of amino acids (the building blocks of proteins) linked by peptide bonds.

Think of a peptide as a “mini protein” (or at least a short chain of amino acids) that plays a role in biology, and which can also be leveraged in therapeutics, cosmetics, supplements, etc.

In skincare, for example, peptides are used because they can “tell” skin cells to boost collagen or elastin, or help with repair.  In nutrition / supplements: Peptides (e.g., collagen peptides) are used for muscle recovery, anti-aging, general wellness.

PNGAF's product collection shows they'll be covering all therapies from "Ageless Cellular Energy & Longevity Support" to the most popular peptide, BPC for Rapid Recovery!

But instead of having to insert peptide therapies via a needle subcutaneously (under the skin) as most do, PNGAF is doing something no one else on earth has done: developing a needle-free, transdermal peptide patch that delivers peptides through the skin. No needles. No mixing. No sterile handling. Just results.


RFK JR. + FDA SHIFT = MASSIVE POLICY TAILWIND

Here's a catalyst that NO ONE saw coming. On April 15, 2026, the FDA officially removed 12 peptides from Category 2 (effective April 22, 2026) including BPC-157, PNGAF's flagship patch compound.

Each substance will go before the Pharmacy Compounding Advisory Committee (PCAC), with BPC-157 specifically on the July 23, 2026 PCAC agenda. This is a HUGE deal  and PNGAF was one of the first public companies to respond positively.

For a stock with barely any trading activity, PNGAF could quickly be positioned to capitalize on one of the hottest trends in Health and wellness today. 

 

chart


Needless to say, it may not be long before all of the Street has this quiet Hidden Gem on their screens!


THE BOTTOM LINE

Traders — let's be real. You've been hearing about peptides for years. You've seen the biohacking world go absolutely VIRAL over BPC-157, TB4, and the rest.

But here's what nobody solved... until now: the needle.

PNGAF's story is simple, an FDA play that could be well positioned to capitalize on a trend that is already going VIRAL!

Make sure you put PNGAF on your screen RIGHT NOW and Follow on Twitter  for Updates + Play-by-Play!

Good Trading,

Editor
StockoftheWeek.net


sms       telegram


Still need an Online Broker to place trades?
Etrade  

Do NOT use RobinHood! Our Team HIGHLY recommends ETRADE .
 


Website   |   Unsubscribe   |   View in Browser

Disclaimer1
We encourage all to read the SEC's INVESTOR ALERT before reading this Newsletter.

COMPENSATION:   Stockoftheweek.net has been compensated twenty thousand dollars cash via bank wire by a third party, Emerging Markets Consulting, LLC for this Precision Peptide Company Inc (formerly Pangea Natural Food Inc.) marketing services contract. Stockoftheweek.net does not own any shares of PNGAF. Stockoftheweek.net has been previously compensated fifty-five thousand dollars cash via bank wire by a third party, LFG Equities Corp. and Emerging Markets Consulting, LLC. for multiple Precision Peptide Company Inc (formerly Pangea Natural Food Inc.) marketing services contracts which have expired.  Stockoftheweek.net does not investigate the background of any third party. The third party may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company.

Disclaimer2